By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



100 Cumming Center, Suite 151-B
Suite A225
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-236-8717 Fax: 978-921-6564


Company News
Cellceutix (CTIX) Comes Out Swinging After Anonymous Seeking Alpha Blog Post 8/7/2015 7:19:29 AM
IRB Approves Additional Enrollment In Cellceutix (CTIX)'s Clinical Trial Of New Cancer Drug Candidate For Solid Tumors 5/22/2015 11:08:02 AM
Cellceutix (CTIX) Reports Results For Quarter Ended March 31, 2015; Enrollment For Oral Mucositis Studies To Begin This Month 5/13/2015 11:35:41 AM
Cellceutix (CTIX) Selects Independent Directors And Committee Members 4/28/2015 11:07:33 AM
Cellceutix (CTIX) Provides Corporate Update 4/23/2015 1:28:51 PM
Cellceutix (CTIX) PIND Meeting Scheduled With FDA For Hidradenitis Suppurativa 4/13/2015 10:19:59 AM
Cellceutix (CTIX) Enters Into A $30 Million Common Stock Purchase Agreement 4/2/2015 11:15:43 AM
Tenth Cohort Completed In Cellceutix (CTIX) Clinical Trial Of Anti-Cancer Drug Kevetrin, No Adverse Events Reported 3/25/2015 11:49:15 AM
Cellceutix (CTIX) Advancing Treatment for Hidradenitis Suppurativa, Pre-IND Meeting Request To FDA 3/16/2015 11:29:46 AM
Cellceutix (CTIX) To Expand Its Skin Product Pipeline 3/3/2015 9:42:39 AM